EUCTR2011-001724-38-IT进行中（未招募）不适用
se of 68-Ga-DOTANOC for the assessment of human neuroendocrine tumors by imaging with Positron Emission Tomography (PET) - 68-Ga-DOTANOC in neuroendocrine tumors
OSPEDALE SACRO CUORE-DON CALABRIA0 个研究点开始时间: 2012年3月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Age > 18 years; male or female; tumor of neuroendocrine origine
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 40
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 10
排除标准
- •< 18 years; pregnancy; breast-feed; incapable to intend
研究者
相似试验
进行中（未招募）
不适用
se of 68Ga-DOTA-NOC for the evaluation of patients with Idiopathic pulmonary fibrosisSTUDY CODE: 68Ga-DOTA-NOC/ILD 01/2008 - 68Ga-DOTA-NOC/ILD01/2008EUCTR2008-007168-40-ITAZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
终止
1 期
Phase I/IIa Study of 68GaNOTA-Anti-MMR-VHH2 for PET/CTMalignant Solid TumorMelanoma (Skin)Breast CancerNCT04168528Universitair Ziekenhuis Brussel13
进行中（未招募）
不适用
Appraisal of the role of the 68Ga-DOTANOC in the diagnostic by Positron emission tomography (PET) in the study of human tumors of neuroendocrine derivation - NDtumors of neuroendocrine derivationMedDRA version: 6.1Level: HLGTClassification code 10029112EUCTR2006-001614-33-ITAZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
进行中（未招募）
不适用
A prospective study of the use of 68Ga-DOTA-TATE PET/CT in patients with neuroendocrine tumors.Patients with neuroendocrine tumors, who are going to be diagnosed/evaluated with 68Ga-DOTA-TATE PET/CT instead of standard OctreoscanMedDRA version: 14.1Level: LLTClassification code 10062476Term: Neuroendocrine tumorSystem Organ Class: 100000004864EUCTR2012-004313-13-SESkåne University Hospital, Dept of Oncology450
进行中（未招募）
不适用
68Ga-DOTANOC as a PET tool to diagnose nueroendocrine tumors - NDStudy of tumor neuroendocrin originEUCTR2010-022975-67-ITAZIENDA U.L.S.S. N.8 DI ASOLO